GAMCO Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2M Buy
26,339
+1,463
+6% +$1.48M 0.24% 115
2025
Q4
$26.7M Sell
24,876
-106
-0.4% -$101K 0.26% 105
2025
Q3
$19.1M Sell
24,982
-2,417
-9% -$1.8M 0.18% 140
2025
Q2
$21.4M Sell
27,399
-2,671
-9% -$2.08M 0.21% 129
2025
Q1
$24.8M Sell
30,070
-3,473
-10% -$2.89M 0.27% 100
2024
Q4
$25.9M Sell
33,543
-1,269
-4% -$1.05M 0.27% 101
2024
Q3
$30.8M Sell
34,812
-1,017
-3% -$914K 0.32% 87
2024
Q2
$32.4M Sell
35,829
-520
-1% -$416K 0.35% 76
2024
Q1
$28.3M Sell
36,349
-286
-0.8% -$204K 0.29% 90
2023
Q4
$21.4M Buy
36,635
+6,054
+20% +$3.53M 0.23% 120
2023
Q3
$16.4M Sell
30,581
-893
-3% -$460K 0.19% 145
2023
Q2
$14.8M Buy
31,474
+941
+3% +$395K 0.16% 167
2023
Q1
$10.5M Sell
30,533
-322
-1% -$109K 0.11% 219
2022
Q4
$11.3M Buy
30,855
+11,759
+62% +$4.17M 0.12% 200
2022
Q3
$6.17M Buy
19,096
+726
+4% +$230K 0.07% 279
2022
Q2
$5.96M Sell
18,370
-545
-3% -$164K 0.07% 293
2022
Q1
$5.42M Sell
18,915
-225
-1% -$57.9K 0.05% 330
2021
Q4
$5.29M Sell
19,140
-125
-0.6% -$31.7K 0.05% 337
2021
Q3
$4.45M Sell
19,265
-714
-4% -$176K 0.04% 370
2021
Q2
$4.59M Sell
19,979
-1,216
-6% -$244K 0.04% 374
2021
Q1
$3.96M Buy
21,195
+83
+0.4% +$16.2K 0.03% 382
2020
Q4
$3.56M Sell
21,112
-1,392
-6% -$208K 0.03% 375
2020
Q3
$3.33M Buy
22,504
+192
+0.9% +$29.7K 0.04% 378
2020
Q2
$3.66M Sell
22,312
-5,400
-19% -$829K 0.04% 358
2020
Q1
$3.84M Sell
27,712
-1,900
-6% -$261K 0.05% 333
2019
Q4
$3.89M Sell
29,612
-3,625
-11% -$420K 0.03% 390
2019
Q3
$3.72M Sell
33,237
-1,200
-3% -$134K 0.03% 396
2019
Q2
$3.81M Buy
34,437
+9,300
+37% +$1.1M 0.03% 397
2019
Q1
$3.26M Sell
25,137
-11,103
-31% -$1.35M 0.02% 419
2018
Q4
$4.19M Sell
36,240
-4,525
-11% -$505K 0.04% 351
2018
Q3
$4.37M Sell
40,765
-8,550
-17% -$855K 0.03% 377
2018
Q2
$4.21M Sell
49,315
-1,635
-3% -$134K 0.03% 378
2018
Q1
$3.94M Sell
50,950
-1,150
-2% -$92.6K 0.03% 384
2017
Q4
$4.4M Sell
52,100
-21,750
-29% -$1.85M 0.03% 381
2017
Q3
$6.32M Sell
73,850
-2,950
-4% -$242K 0.04% 332
2017
Q2
$6.32M Sell
76,800
-2,300
-3% -$188K 0.04% 329
2017
Q1
$6.65M Sell
79,100
-1,450
-2% -$116K 0.04% 325
2016
Q4
$5.92M Sell
80,550
-1,500
-2% -$112K 0.04% 340
2016
Q3
$6.58M Sell
82,050
-700
-0.8% -$56K 0.04% 320
2016
Q2
$6.52M Sell
82,750
-1,200
-1% -$90.3K 0.04% 324
2016
Q1
$6.04M Sell
83,950
-400
-0.5% -$30.3K 0.04% 338
2015
Q4
$7.11M Sell
84,350
-13,550
-14% -$1.12M 0.05% 314
2015
Q3
$8.19M Hold
97,900
0.05% 288
2015
Q2
$8.17M Sell
97,900
-13,900
-12% -$1.06M 0.04% 316
2015
Q1
$8.12M Sell
111,800
-2,000
-2% -$142K 0.04% 323
2014
Q4
$7.85M Sell
113,800
-800
-0.7% -$54K 0.04% 338
2014
Q3
$7.43M Sell
114,600
-5,400
-5% -$342K 0.04% 341
2014
Q2
$7.46M Sell
120,000
-900
-0.7% -$53.7K 0.04% 342
2014
Q1
$7.12M Sell
120,900
-3,000
-2% -$167K 0.04% 347
2013
Q4
$6.32M Sell
123,900
-600
-0.5% -$30K 0.03% 364
2013
Q3
$6.27M Sell
124,500
-2,500
-2% -$131K 0.04% 357
2013
Q2
$6.24M Buy
+127,000
New +$6.91M 0.04% 345

Other funds holding LLY

GAMCO Investors's LLY Position: Q1 2026 in Review

GAMCO Investors increased its Eli Lilly (LLY) stake by 5.9% in Q1 2026, buying an estimated $1.48M and bringing the position to 26,339 shares worth $24.2M. The position accounts for 0.24% of the portfolio, ranked #115.

GAMCO Investors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.4M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GAMCO Investors held 26,339 shares of Eli Lilly worth $24.2M as of Q1 2026.
  • GAMCO Investors bought 1,463 Eli Lilly shares in Q1 2026, an estimated $1.48M.
  • Eli Lilly made up 0.24% of GAMCO Investors's portfolio in Q1 2026, its #115 holding.
  • GAMCO Investors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • GAMCO Investors's Eli Lilly position peaked at $32.4M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.